Date
Sponsor content
1 result(s) found, displaying 1 to 1
-
Jan-2026Prescription medicine evaluationActive ingredient: efbemalenograstim alfa.
Vitalis Therapeutics
Regulatory activities for this sponsor.
Regulatory activities for this sponsor.